Home » Authors » James Etheridge

Articles by James Etheridge

Pierre Fabre Seeks EMEA Nod for Milnacipran in Fibromyalgia

June 18, 2008

By James Etheridge

SiRNAsense Picks Polyplus's in Vivo Delivery Platform

June 18, 2008

By James Etheridge

Transgene's TG4010 Vaccine Meets Phase IIb Trial Endpoint

June 11, 2008

By James Etheridge

Edmond de Rothschild Closes 150 Million BioDiscovery Fund

June 4, 2008

By James Etheridge

Innate Launches Preclinical Work on First Antibody in Novo Deal

June 4, 2008

By James Etheridge

BioAlliance Buys Rights to NovaDel's Ondansetron

May 28, 2008

By James Etheridge

Trophos Launches Phase II Trial of TRO19622 in Liver Disease

May 21, 2008

By James Etheridge

NicOx Antihypertensive Taken Into Phase I Trial by Merck

May 14, 2008

By James Etheridge

Polyplus-transfection Unveils New siRNA Technology

April 30, 2008

By James Etheridge

Sanofi-Aventis Stops Developing Two Genfit Drug Candidates

April 9, 2008

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...